Move to ban fixed-dose combinations a culmination of efforts to free market from irrational drugsThe US Food & Drug Administration has favoured use of FDCs for HIV treatments, but approval process is rigorous.
17 Mar, 2016, 01.48 AM IST
TB treatment could be shortened, show trialsThe effectiveness of the four-month regimen was proved on the basis of recurrence levels, number of patients testing negative in sputum sme...
25 Nov, 2014, 11.16 AM IST
- World TB day: Need to raise public spend on clinical trials & find innovative ways to incentivise R&D
March 24 is World TB day. It commemorates the discovery of Tuberculosis (TB) bacillus in 1883 by Dr Robert Koch as the cause of tuberculosi...
24 Mar, 2012, 06.09 AM IST
- Lupin signs strategic deal with Brazilian firm Farmanguinhos
Pharma Major, Lupin Ltd today announced that it has entered into an agreement with Farmanguinhos for the supply of its 4 in 1 combination d...
05 Jan, 2011, 03.43 PM IST
- Lupin inks pact with Brazil for TB drug supply for 5 yrs
Drug firm Lupin today said it has signed an agreement with Brazil to supply its four-in-one combination drug to treat tuberculosis.
05 Jan, 2011, 02.09 PM IST
- Mid-cap pharma firms focus on LatAm market
Lupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American natio...
11 Sep, 2009, 12.21 AM IST
Only 33 drugs to stay under price controlIT will be a mixed bag for the pharma industry. Pharma multinationals and domestic drug majors are expected to gain enormously with the che...
18 Dec, 2001, 02.09 AM IST